EMEA (Europe, Middle East and Africa) Prostate Specific Antigen Market Report 2018

January 2018 | 103 pages | ID: EC62E1C8BB2EN
QYResearch

Abstracts

In this report, the EMEA Prostate Specific Antigen market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Prostate Specific Antigen for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Prostate Specific Antigen market competition by top manufacturers/players, with Prostate Specific Antigen sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Advaxis, Inc.
• Aeterna Zentaris Inc.
• Bavarian Nordic A/S
• Curevac AG
• GenSpera, Inc.
• Inovio Pharmaceuticals, Inc.
• OncBioMune Pharmaceuticals Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• G-115
• INO-5150
• ADXS-PSA
• AEZS-120
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prostate Cancer
• Metastatic Hormone Refractory Prostate Cancer
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Prostate Specific Antigen Market Report 2017

1 PROSTATE SPECIFIC ANTIGEN OVERVIEW

1.1 Product Overview and Scope of Prostate Specific Antigen
1.2 Classification of Prostate Specific Antigen
  1.2.1 EMEA Prostate Specific Antigen Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Prostate Specific Antigen Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 G-115
  1.2.4 INO-5150
  1.2.5 ADXS-PSA
  1.2.6 AEZS-120
  1.2.7 Others
1.3 EMEA Prostate Specific Antigen Market by Application/End Users
  1.3.1 EMEA Prostate Specific Antigen Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Prostate Cancer
  1.3.3 Metastatic Hormone Refractory Prostate Cancer
  1.3.4 Others
1.4 EMEA Prostate Specific Antigen Market by Region
  1.4.1 EMEA Prostate Specific Antigen Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Prostate Specific Antigen (2012-2022)
  1.5.1 EMEA Prostate Specific Antigen Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Prostate Specific Antigen Revenue and Growth Rate (2012-2022)

2 EMEA PROSTATE SPECIFIC ANTIGEN COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Prostate Specific Antigen Market Competition by Players/Manufacturers
  2.1.1 EMEA Prostate Specific Antigen Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Prostate Specific Antigen Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Prostate Specific Antigen Sale Price by Players (2012-2017)
2.2 EMEA Prostate Specific Antigen (Volume and Value) by Type/Product Category
  2.2.1 EMEA Prostate Specific Antigen Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Prostate Specific Antigen Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Prostate Specific Antigen Sale Price by Type (2012-2017)
2.3 EMEA Prostate Specific Antigen (Volume) by Application
2.4 EMEA Prostate Specific Antigen (Volume and Value) by Region
  2.4.1 EMEA Prostate Specific Antigen Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Prostate Specific Antigen Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Prostate Specific Antigen Sales Price by Region (2012-2017)

3 EUROPE PROSTATE SPECIFIC ANTIGEN (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Prostate Specific Antigen Sales and Value (2012-2017)
  3.1.1 Europe Prostate Specific Antigen Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Prostate Specific Antigen Revenue and Growth Rate (2012-2017)
3.2 Europe Prostate Specific Antigen Sales and Market Share by Type
3.3 Europe Prostate Specific Antigen Sales and Market Share by Application
3.4 Europe Prostate Specific Antigen Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Prostate Specific Antigen Sales Volume by Countries (2012-2017)
  3.4.2 Europe Prostate Specific Antigen Revenue by Countries (2012-2017)
  3.4.3 Germany Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  3.4.4 France Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  3.4.5 UK Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  3.4.6 Russia Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  3.4.7 Italy Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Prostate Specific Antigen Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PROSTATE SPECIFIC ANTIGEN (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Prostate Specific Antigen Sales and Value (2012-2017)
  4.1.1 Middle East Prostate Specific Antigen Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Prostate Specific Antigen Revenue and Growth Rate (2012-2017)
4.2 Middle East Prostate Specific Antigen Sales and Market Share by Type
4.3 Middle East Prostate Specific Antigen Sales and Market Share by Application
4.4 Middle East Prostate Specific Antigen Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Prostate Specific Antigen Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Prostate Specific Antigen Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  4.4.4 Israel Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  4.4.5 UAE Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  4.4.6 Iran Prostate Specific Antigen Sales and Growth Rate (2012-2017)

5 AFRICA PROSTATE SPECIFIC ANTIGEN (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Prostate Specific Antigen Sales and Value (2012-2017)
  5.1.1 Africa Prostate Specific Antigen Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Prostate Specific Antigen Revenue and Growth Rate (2012-2017)
5.2 Africa Prostate Specific Antigen Sales and Market Share by Type
5.3 Africa Prostate Specific Antigen Sales and Market Share by Application
5.4 Africa Prostate Specific Antigen Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Prostate Specific Antigen Sales Volume by Countries (2012-2017)
  5.4.2 Africa Prostate Specific Antigen Revenue by Countries (2012-2017)
  5.4.3 South Africa Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Prostate Specific Antigen Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Prostate Specific Antigen Sales and Growth Rate (2012-2017)

6 EMEA PROSTATE SPECIFIC ANTIGEN MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Advaxis, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostate Specific Antigen Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Aeterna Zentaris Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Prostate Specific Antigen Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bavarian Nordic A/S
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Prostate Specific Antigen Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Curevac AG
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Prostate Specific Antigen Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GenSpera, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Prostate Specific Antigen Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Inovio Pharmaceuticals, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Prostate Specific Antigen Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 OncBioMune Pharmaceuticals Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Prostate Specific Antigen Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 PROSTATE SPECIFIC ANTIGEN MANUFACTURING COST ANALYSIS

7.1 Prostate Specific Antigen Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostate Specific Antigen

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostate Specific Antigen Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostate Specific Antigen Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PROSTATE SPECIFIC ANTIGEN MARKET FORECAST (2017-2022)

11.1 EMEA Prostate Specific Antigen Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Prostate Specific Antigen Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Prostate Specific Antigen Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Prostate Specific Antigen Price and Trend Forecast (2017-2022)
11.2 EMEA Prostate Specific Antigen Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Prostate Specific Antigen Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Prostate Specific Antigen Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Prostate Specific Antigen Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Prostate Specific Antigen Sales Forecast by Type (2017-2022)
11.7 EMEA Prostate Specific Antigen Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Prostate Specific Antigen
Figure EMEA Prostate Specific Antigen Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Prostate Specific Antigen Sales Volume Market Share by Type (Product Category) in 2016
Figure G-115 Product Picture
Figure INO-5150 Product Picture
Figure ADXS-PSA Product Picture
Figure AEZS-120 Product Picture
Figure Others Product Picture
Figure EMEA Prostate Specific Antigen Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Prostate Specific Antigen by Application in 2016
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Metastatic Hormone Refractory Prostate Cancer Examples
Table Key Downstream Customer in Metastatic Hormone Refractory Prostate Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Prostate Specific Antigen Market Size (Million USD) by Region (2012-2022)
Figure Europe Prostate Specific Antigen Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Prostate Specific Antigen Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Prostate Specific Antigen Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Prostate Specific Antigen Revenue (Million USD) Status and Forecast by Countries
Figure Africa Prostate Specific Antigen Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Prostate Specific Antigen Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Prostate Specific Antigen Sales Volume and Growth Rate (2012-2022)
Figure EMEA Prostate Specific Antigen Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Prostate Specific Antigen Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Prostate Specific Antigen Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Prostate Specific Antigen Sales Share by Players (2012-2017)
Figure 2016 Prostate Specific Antigen Sales Share by Players
Figure 2017 Prostate Specific Antigen Sales Share by Players
Figure EMEA Prostate Specific Antigen Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Prostate Specific Antigen Revenue (Million USD) by Players (2012-2017)
Table EMEA Prostate Specific Antigen Revenue Share by Players (2012-2017)
Table 2016 EMEA Prostate Specific Antigen Revenue Share by Players
Table 2017 EMEA Prostate Specific Antigen Revenue Share by Players
Table EMEA Prostate Specific Antigen Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Prostate Specific Antigen Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Prostate Specific Antigen Sales Share by Type (2012-2017)
Figure Sales Market Share of Prostate Specific Antigen by Type (2012-2017)
Figure EMEA Prostate Specific Antigen Sales Market Share by Type (2012-2017)
Table EMEA Prostate Specific Antigen Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Prostate Specific Antigen Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Specific Antigen by Type in 2016
Table EMEA Prostate Specific Antigen Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Prostate Specific Antigen Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Prostate Specific Antigen Sales Share by Application (2012-2017)
Figure Sales Market Share of Prostate Specific Antigen by Application (2012-2017)
Figure EMEA Prostate Specific Antigen Sales Market Share by Application in 2016
Table EMEA Prostate Specific Antigen Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Prostate Specific Antigen Sales Share by Region (2012-2017)
Figure Sales Market Share of Prostate Specific Antigen by Region (2012-2017)
Figure EMEA Prostate Specific Antigen Sales Market Share in 2016
Table EMEA Prostate Specific Antigen Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Prostate Specific Antigen Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Prostate Specific Antigen by Region (2012-2017)
Figure EMEA Prostate Specific Antigen Revenue Market Share Regions in 2016
Table EMEA Prostate Specific Antigen Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Prostate Specific Antigen Revenue and Growth Rate (2012-2017)
Table Europe Prostate Specific Antigen Sales (K Pcs) by Type (2012-2017)
Table Europe Prostate Specific Antigen Market Share by Type (2012-2017)
Figure Europe Prostate Specific Antigen Market Share by Type in 2016
Table Europe Prostate Specific Antigen Sales (K Pcs) by Application (2012-2017)
Table Europe Prostate Specific Antigen Market Share by Application (2012-2017)
Figure Europe Prostate Specific Antigen Market Share by Application in 2016
Table Europe Prostate Specific Antigen Sales (K Pcs) by Countries (2012-2017)
Table Europe Prostate Specific Antigen Sales Market Share by Countries (2012-2017)
Figure Europe Prostate Specific Antigen Sales Market Share by Countries (2012-2017)
Figure Europe Prostate Specific Antigen Sales Market Share by Countries in 2016
Table Europe Prostate Specific Antigen Revenue (Million USD) by Countries (2012-2017)
Table Europe Prostate Specific Antigen Revenue Market Share by Countries (2012-2017)
Figure Europe Prostate Specific Antigen Revenue Market Share by Countries (2012-2017)
Figure Europe Prostate Specific Antigen Revenue Market Share by Countries in 2016
Figure Germany Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Prostate Specific Antigen Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Prostate Specific Antigen Sales (K Pcs) by Type (2012-2017)
Table Middle East Prostate Specific Antigen Market Share by Type (2012-2017)
Figure Middle East Prostate Specific Antigen Market Share by Type (2012-2017)
Table Middle East Prostate Specific Antigen Sales (K Pcs) by Applications (2012-2017)
Table Middle East Prostate Specific Antigen Market Share by Applications (2012-2017)
Figure Middle East Prostate Specific Antigen Sales Market Share by Application in 2016
Table Middle East Prostate Specific Antigen Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Prostate Specific Antigen Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Prostate Specific Antigen Sales Volume Market Share by Countries in 2016
Table Middle East Prostate Specific Antigen Revenue (Million USD) by Countries (2012-2017)
Table Middle East Prostate Specific Antigen Revenue Market Share by Countries (2012-2017)
Figure Middle East Prostate Specific Antigen Revenue Market Share by Countries (2012-2017)
Figure Middle East Prostate Specific Antigen Revenue Market Share by Countries in 2016
Figure Saudi Arabia Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Prostate Specific Antigen Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Prostate Specific Antigen Sales (K Pcs) by Type (2012-2017)
Table Africa Prostate Specific Antigen Sales Market Share by Type (2012-2017)
Figure Africa Prostate Specific Antigen Sales Market Share by Type (2012-2017)
Figure Africa Prostate Specific Antigen Sales Market Share by Type in 2016
Table Africa Prostate Specific Antigen Sales (K Pcs) by Application (2012-2017)
Table Africa Prostate Specific Antigen Sales Market Share by Application (2012-2017)
Figure Africa Prostate Specific Antigen Sales Market Share by Application (2012-2017)
Table Africa Prostate Specific Antigen Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Prostate Specific Antigen Sales Market Share by Countries (2012-2017)
Figure Africa Prostate Specific Antigen Sales Market Share by Countries (2012-2017)
Figure Africa Prostate Specific Antigen Sales Market Share by Countries in 2016
Table Africa Prostate Specific Antigen Revenue (Million USD) by Countries (2012-2017)
Table Africa Prostate Specific Antigen Revenue Market Share by Countries (2012-2017)
Figure Africa Prostate Specific Antigen Revenue Market Share by Countries (2012-2017)
Figure Africa Prostate Specific Antigen Revenue Market Share by Countries in 2016
Figure South Africa Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Table Advaxis, Inc. Prostate Specific Antigen Basic Information List
Table Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advaxis, Inc. Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Advaxis, Inc. Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure Advaxis, Inc. Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table Aeterna Zentaris Inc. Prostate Specific Antigen Basic Information List
Table Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aeterna Zentaris Inc. Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Aeterna Zentaris Inc. Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure Aeterna Zentaris Inc. Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table Bavarian Nordic A/S Prostate Specific Antigen Basic Information List
Table Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bavarian Nordic A/S Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bavarian Nordic A/S Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure Bavarian Nordic A/S Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table Curevac AG Prostate Specific Antigen Basic Information List
Table Curevac AG Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Curevac AG Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Curevac AG Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure Curevac AG Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table GenSpera, Inc. Prostate Specific Antigen Basic Information List
Table GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GenSpera, Inc. Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure GenSpera, Inc. Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure GenSpera, Inc. Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Basic Information List
Table Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Basic Information List
Table OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales (K Pcs) and Growth Rate (2012-2017)
Figure OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales Market Share in EMEA (2012-2017)
Figure OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Specific Antigen
Figure Manufacturing Process Analysis of Prostate Specific Antigen
Figure Prostate Specific Antigen Industrial Chain Analysis
Table Raw Materials Sources of Prostate Specific Antigen Major Manufacturers in 2016
Table Major Buyers of Prostate Specific Antigen
Table Distributors/Traders List
Figure EMEA Prostate Specific Antigen Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Prostate Specific Antigen Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Prostate Specific Antigen Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Prostate Specific Antigen Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Prostate Specific Antigen Sales Market Share Forecast by Region (2017-2022)
Table EMEA Prostate Specific Antigen Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Prostate Specific Antigen Revenue Market Share Forecast by Region (2017-2022)
Table Europe Prostate Specific Antigen Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Prostate Specific Antigen Sales Market Share Forecast by Countries (2017-2022)
Table Europe Prostate Specific Antigen Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Prostate Specific Antigen Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Prostate Specific Antigen Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Prostate Specific Antigen Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Prostate Specific Antigen Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Prostate Specific Antigen Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Prostate Specific Antigen Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Prostate Specific Antigen Sales Market Share Forecast by Countries (2017-2022)
Table Africa Prostate Specific Antigen Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Prostate Specific Antigen Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Prostate Specific Antigen Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Prostate Specific Antigen Sales Market Share Forecast by Type (2017-2022)
Table EMEA Prostate Specific Antigen Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Prostate Specific Antigen Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources